Pathogenesis-based treatment of type 1 diabetes

1型糖尿病的发病机制治疗

• 批准号: nhmrc : 1037321
• 负责人: A/Pr Helen Thomas
• 金额: $ 720.7万
• 依托单位: St. Vincent's Institute of Medical Research
• 依托单位国家: 澳大利亚
• 项目类别: Program Grants
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/pathogenesis-based-treatment-1-diabetes/111070
• 关键词: Pathogenesis; based; treatment; type; diabetes

At least 6 young Australians are diagnosed each day with type 1 diabetes. This Program aims to change the way type 1 diabetes is managed by proactively treating its underlying mechanisms. We will develop safer and more effective immune therapies, develop islet transplantation, look for better markers of disease, and identify ways to preserve insulin-producing cells. The Program aims to propel type 1 diabetes research forward to reach the goals of prevention and cure.

每天至少有6名澳大利亚年轻人被诊断患有1型糖尿病。该计划旨在通过积极治疗其潜在机制来改变1型糖尿病的管理方式。我们将开发更安全和更有效的免疫疗法，开发胰岛移植，寻找更好的疾病标志物，并确定保存胰岛素产生细胞的方法。该计划旨在推动1型糖尿病的研究，以达到预防和治疗的目标。